Last week, a bill was re-introduced in the Colorado Senate, which would allow pharmacists to substitute a biosimilar for a branded biologic. Colorado legislatures are once again being asked to review Senate Bill 71, an idea that failed in the Legislature two years ago. When first proposed in 2013, the …